Embolization of an insulinoma of the pancreas with trisacryl gelatin microspheres as definitive treatment.
Insulinomas are rare, mostly benign neuroendocrine tumors, originating in 99% of cases from the pancreas, that synthesize and secrete insulin, causing symptomatic hypoglycemia. Today the treatment of choice is surgical removal. We present the case of an 84-year-old woman with a symptomatic insulinoma who refused surgery and was treated with arterial embolization using trisacryl gelatin microspheres as definitive treatment.
Rott
Gernot
G
Medizinische Klinik, Bethesda-Krankenhaus Duisburg, Heerstrasse 219, Duisburg 47053, Germany. gernot.rott@t-online.de
Biggemann
Martin
M
Pfohl
Martin
M
D000180:Acrylic Resins / Q000008:administration & dosage*; D000369:Aged, 80 and over; D000792:Angiography; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D005780:Gelatin / Q000008:administration & dosage*; D006801:Humans; D007340:Insulinoma / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D007902:Length of Stay; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D018570:Risk Assessment; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000180:Acrylic Resins; C496735:trisacryl gelatin microspheres; D005780:Gelatin